The so-called "vaccine court," which has handled such disputes, was designed to ensure a reliable, steady supply of vaccines by reducing the threat of expensive lawsuits against pharmaceutical firms.
"Taxing vaccine manufacturers' product to fund the compensation program,while leaving their liability for design defects virtually unaltered, would be an odd way to make vaccine manufacture more effective," said Scalia.
After the third series, according to court briefs, the child began having seizures and became disabled.
The "vaccine court" rejected the initial claim, so the family tried to revive the lawsuit in separate state and federal courts.
"Manufacturers, given the lack of robust competition in the vaccine market, will often have little or no incentive to improve the designs of vaccines that are already generating significant profit margins," wrote Sotomayor.
Kagan, now a Supreme Court justice, sat out of the case to avoid a conflict of interest in the eventual ruling.
"Childhood vaccines are among the greatest medical breakthroughs of the last century," said Dr. O. Marion Burton, president of the American Academy of Pediatrics, which represents 60,000 physicians.
Now 14, the boy is unable to speak, say his parents, Stefano and Carolyn Ferrari.
The special federal court created under the legislation was a liability shield, designed to be a reliable, relatively quick, no-fault solution to various claims.
The current high court case is Bruesewitz v. Wyeth (09-152).